State Street Corp lowered its position in Patheon N.V. (NYSE:PTHN) by 4.0% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 413,071 shares of the company’s stock after selling 17,077 shares during the period. State Street Corp owned approximately 0.28% of Patheon N.V. worth $14,409,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Geode Capital Management LLC grew its holdings in Patheon N.V. by 20.9% during the 1st quarter. Geode Capital Management LLC now owns 47,625 shares of the company’s stock valued at $1,254,000 after buying an additional 8,227 shares during the last quarter. Alpine Associates Management Inc. purchased a new position in shares of Patheon N.V. during the 2nd quarter worth $35,624,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new position in shares of Patheon N.V. during the 2nd quarter worth $12,457,000. Goldman Sachs Group Inc. lifted its stake in shares of Patheon N.V. by 48.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 100,293 shares of the company’s stock worth $2,642,000 after purchasing an additional 32,718 shares during the period. Finally, Eaton Vance Management purchased a new position in shares of Patheon N.V. during the 2nd quarter worth $7,394,000. Institutional investors and hedge funds own 12.23% of the company’s stock.

Shares of Patheon N.V. (NYSE:PTHN) opened at $34.98 on Thursday. Patheon N.V. has a twelve month low of $23.72 and a twelve month high of $35.13. The stock has a market capitalization of $5,076.86, a price-to-earnings ratio of 45.43 and a beta of 3.06. The company has a debt-to-equity ratio of -7.33, a current ratio of 1.65 and a quick ratio of 0.91.

WARNING: “Patheon N.V. (PTHN) Holdings Cut by State Street Corp” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at

Separately, BidaskClub lowered Patheon N.V. from a “sell” rating to a “strong sell” rating in a research note on Saturday, September 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $33.60.

Patheon N.V. Profile

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company’s segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products.

Want to see what other hedge funds are holding PTHN? Visit to get the latest 13F filings and insider trades for Patheon N.V. (NYSE:PTHN).

Institutional Ownership by Quarter for Patheon N.V. (NYSE:PTHN)

Receive News & Ratings for Patheon N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patheon N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.